MX2021014578A - Azepinas como moduladores del ensamblaje de la cápside del vhb. - Google Patents
Azepinas como moduladores del ensamblaje de la cápside del vhb.Info
- Publication number
- MX2021014578A MX2021014578A MX2021014578A MX2021014578A MX2021014578A MX 2021014578 A MX2021014578 A MX 2021014578A MX 2021014578 A MX2021014578 A MX 2021014578A MX 2021014578 A MX2021014578 A MX 2021014578A MX 2021014578 A MX2021014578 A MX 2021014578A
- Authority
- MX
- Mexico
- Prior art keywords
- azepines
- capsid assembly
- hbv capsid
- assembly modulators
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Se divulgan compuestos, composiciones y métodos para tratar enfermedades, síndromes, afecciones y trastornos que se ven afectados por la modulación de CAM1; tales compuestos se representan mediante la Fórmula (I) tal como sigue: (ver fórmula) en donde R1 , R2 , R3 , R4 , X e Y se definen en la presente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962853556P | 2019-05-28 | 2019-05-28 | |
PCT/EP2020/064746 WO2020239861A1 (en) | 2019-05-28 | 2020-05-27 | Azepines as hbv capsid assembly modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021014578A true MX2021014578A (es) | 2022-03-17 |
Family
ID=70968927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021014578A MX2021014578A (es) | 2019-05-28 | 2020-05-27 | Azepinas como moduladores del ensamblaje de la cápside del vhb. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20220251114A1 (es) |
EP (1) | EP3976613A1 (es) |
JP (1) | JP2022534961A (es) |
KR (1) | KR20220015421A (es) |
CN (1) | CN113891890A (es) |
AU (1) | AU2020281802A1 (es) |
BR (1) | BR112021023651A2 (es) |
CA (1) | CA3138149A1 (es) |
MX (1) | MX2021014578A (es) |
WO (1) | WO2020239861A1 (es) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2972434A1 (en) * | 2014-12-30 | 2016-07-07 | Novira Therapeutics, Inc. | Derivatives and methods of treating hepatitis b infections |
US10875876B2 (en) * | 2015-07-02 | 2020-12-29 | Janssen Sciences Ireland Uc | Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B |
EP3478683B1 (en) * | 2016-06-29 | 2021-07-21 | Novira Therapeutics Inc. | Diazepinone derivatives and their use in the treatment of hepatitis b infections |
-
2020
- 2020-05-27 US US17/595,537 patent/US20220251114A1/en active Pending
- 2020-05-27 BR BR112021023651A patent/BR112021023651A2/pt not_active Application Discontinuation
- 2020-05-27 KR KR1020217042054A patent/KR20220015421A/ko unknown
- 2020-05-27 WO PCT/EP2020/064746 patent/WO2020239861A1/en unknown
- 2020-05-27 EP EP20729986.8A patent/EP3976613A1/en not_active Withdrawn
- 2020-05-27 CA CA3138149A patent/CA3138149A1/en active Pending
- 2020-05-27 MX MX2021014578A patent/MX2021014578A/es unknown
- 2020-05-27 JP JP2021570715A patent/JP2022534961A/ja active Pending
- 2020-05-27 CN CN202080039635.6A patent/CN113891890A/zh active Pending
- 2020-05-27 AU AU2020281802A patent/AU2020281802A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20220251114A1 (en) | 2022-08-11 |
CA3138149A1 (en) | 2020-12-03 |
WO2020239861A1 (en) | 2020-12-03 |
AU2020281802A1 (en) | 2021-11-25 |
EP3976613A1 (en) | 2022-04-06 |
CN113891890A (zh) | 2022-01-04 |
BR112021023651A2 (pt) | 2022-04-12 |
JP2022534961A (ja) | 2022-08-04 |
KR20220015421A (ko) | 2022-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021014350A (es) | Compuestos de 1-oxo-isoindolin-5-carboxamida sustituida, composiciones de los mismos y metodos de tratamiento con los mismos. | |
PH12021551167A1 (en) | New heterocyclic compounds | |
MX2021013193A (es) | Cicloalquilos sustituidos como moduladores de la vía integrada del estrés. | |
CR20210592A (es) | Moduladores de la vía integrada del estrés | |
JO2853B1 (en) | Sulfonamides as TRPM8 organizations | |
EA202092248A1 (ru) | Замещенные соединения 4-аминоизоиндолин-1,3-диона, их композиции и способы лечения ими | |
MX2020006290A (es) | Dinucleotidos ciclicos como agonistas de sting. | |
MX2020013899A (es) | Derivados de pirazol como inhibidores de malt1. | |
MX2021012706A (es) | Inhibidores de dihidroorotato deshidrogenasa. | |
MX2010009752A (es) | Compuestos de oxadiazoantraceno para el tratamiento de diabetes. | |
EA201100311A1 (ru) | Амидные производные гетероарилов и их применение в качестве активаторов глюкокиназы | |
WO2019035863A8 (en) | PYRUVATE KINASE ACTIVATORS FOR USE IN THE TREATMENT OF HEMATOLOGICAL DISORDERS | |
MX2021009521A (es) | Inhibidores de dihidroorotato deshidrogenasa. | |
PH12020552206A1 (en) | Pyrazole derivatives as malt1 inhibitors | |
WO2010124121A8 (en) | Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor | |
NZ735648A (en) | Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection | |
MX2021001565A (es) | Inhibidores tipo indol y azaindol de enzimas peptidil arginina deiminasas (pad). | |
PH12020552172A1 (en) | Cyclic dinucleotides as sting agonists | |
EA202190272A1 (ru) | Дополнительно замещенные производные триазолохиноксалина | |
CR20220004A (es) | Nuevos compuestos heterocíclicos | |
EA202190271A1 (ru) | Замещенные триазолохиноксалиновые производные | |
WO2022169961A8 (en) | Sigma receptor ligands for treating sars-cov-2 infection | |
MX2020013827A (es) | Proceso de preparacion de compuestos triciclicos. | |
MX2021014578A (es) | Azepinas como moduladores del ensamblaje de la cápside del vhb. | |
MX2021014580A (es) | Derivados heterociclos condensados como moduladores de ensamblaje de la capside. |